ATE488515T1 - Rosiglitazonhydrochlorid-hemihydrat - Google Patents

Rosiglitazonhydrochlorid-hemihydrat

Info

Publication number
ATE488515T1
ATE488515T1 AT07723463T AT07723463T ATE488515T1 AT E488515 T1 ATE488515 T1 AT E488515T1 AT 07723463 T AT07723463 T AT 07723463T AT 07723463 T AT07723463 T AT 07723463T AT E488515 T1 ATE488515 T1 AT E488515T1
Authority
AT
Austria
Prior art keywords
hydrochloride hemihydrate
compound
provides
rosiglitazone
rosiglitazone hydrochloride
Prior art date
Application number
AT07723463T
Other languages
English (en)
Inventor
Josef Wieser
Arthur Pichler
Hannes Lengauer
Elfriede Klingler
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Application granted granted Critical
Publication of ATE488515T1 publication Critical patent/ATE488515T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
AT07723463T 2006-03-23 2007-03-21 Rosiglitazonhydrochlorid-hemihydrat ATE488515T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP06005969A EP1842850A1 (de) 2006-03-23 2006-03-23 Rosiglitazon hydrochlorid hemihydrat
PCT/EP2007/002506 WO2007107354A1 (en) 2006-03-23 2007-03-21 Rosiglitazone hydrochloride hemihydrate

Publications (1)

Publication Number Publication Date
ATE488515T1 true ATE488515T1 (de) 2010-12-15

Family

ID=37074160

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07723463T ATE488515T1 (de) 2006-03-23 2007-03-21 Rosiglitazonhydrochlorid-hemihydrat

Country Status (5)

Country Link
EP (2) EP1842850A1 (de)
AT (1) ATE488515T1 (de)
CA (1) CA2646627A1 (de)
DE (1) DE602007010612D1 (de)
WO (1) WO2007107354A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UY30730A1 (es) 2006-12-04 2008-07-03 Mitsubishi Tanabe Pharma Corp Forma cristalina del hemihidrato de 1-(b (beta)-d-glucopiranosil) -4-metil-3-[5-(4-fluorofenil) -2-tienilmetil]benceno
CL2008003653A1 (es) 2008-01-17 2010-03-05 Mitsubishi Tanabe Pharma Corp Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
EP2021339B1 (de) 2010-11-17
DE602007010612D1 (de) 2010-12-30
CA2646627A1 (en) 2007-09-27
EP2021339A1 (de) 2009-02-11
EP1842850A1 (de) 2007-10-10
WO2007107354A1 (en) 2007-09-27

Similar Documents

Publication Publication Date Title
NZ515163A (en) Thiazolidinedione derivative and its use as antidiabetic
PH12012501776A1 (en) Crystalline forms of thiazolidinedione compound and its manufacturing method
MY128573A (en) Substituted thiazolidinedione derivative, process for its preparation and its parmaceutical use
NZ515168A (en) Polymorph of 5-[4-[2- (n-methyl-n-( 2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt
NZ515167A (en) Thiazolidinedione derivative and its use as antidiabetic
YU36200A (sh) Hidrat od 5-(4-2-n-metil-n-(2-piridil)amino)etoksi)benzil) tiazolidin-2,4-diona soli maleinske kiseline
DE602007010612D1 (de) Rosiglitazonhydrochlorid-hemihydrat
NZ515166A (en) Thiazolidinedione derivative and its use as antidiabetic
AP1680A (en) Thiazolidinedione derivative and its use as antidiabetic.
WO2010013768A1 (ja) チアゾリジンジオン化合物の結晶及びその製造方法
YU16303A (sh) Tartaratne soli derivata tiazolidindiona
MXPA02012100A (es) Sal de tiazodilindiona para el tratamiento de la diabetes mellitus.
AU2001284285A1 (en) A thiazolidinedione derivative and its use as antidiabetic
WO2005021542A3 (en) Process for the preparation of pioglitazone
AP1785A (en) Tartrate salt of thiazolidinedione derivative.
HUP0301799A3 (en) Use of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide for treating diabetes mellitus, process for preparation thereof and pharmaceutical composition containing the same
AP1841A (en) A thiazolidinedione derivative and its use as antidiabetic.
EA200700568A1 (ru) Способ получения розиглитазона
NZ524933A (en) Sodium salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical composition thereof
WO2008010089A3 (en) Process for preparation of intermediates of rosiglitazone, rosiglitazone and polymorphic forms thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties